Search
Rocket Pharmaceuticals Inc
RCKTAdd to Watchlist
3.250USD
+0.010+0.31%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
352.04MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RTW Investments L.P.
16.20%
BlackRock Institutional Trust Company, N.A.
5.95%
Citi Investment Research (US)
4.68%
Vanguard Portfolio Management, LLC
4.30%
Two Sigma Investments, LP
3.67%
Other
65.21%
Shareholders
Shareholders
Proportion
RTW Investments L.P.
16.20%
BlackRock Institutional Trust Company, N.A.
5.95%
Citi Investment Research (US)
4.68%
Vanguard Portfolio Management, LLC
4.30%
Two Sigma Investments, LP
3.67%
Other
65.21%
Shareholder Types
Shareholders
Proportion
Investment Advisor
30.10%
Investment Advisor/Hedge Fund
28.80%
Hedge Fund
21.07%
Research Firm
10.33%
Individual Investor
2.98%
Venture Capital
0.18%
Bank and Trust
0.13%
Pension Fund
0.11%
Family Office
0.04%
Other
6.28%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
507
107.44M
98.40%
-21.31M
2025Q4
496
99.47M
91.91%
-24.92M
2025Q3
494
97.15M
89.78%
-13.57M
2025Q2
493
101.52M
94.23%
-15.02M
2025Q1
494
114.28M
106.44%
-9.69M
2024Q4
469
115.66M
108.78%
+9.90M
2024Q3
442
99.39M
108.64%
-6.54M
2024Q2
434
97.04M
106.63%
-8.16M
2024Q1
431
98.54M
108.92%
-3.20M
2023Q4
427
94.76M
105.15%
-7.91M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RTW Investments L.P.
17.69M
16.29%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.50M
5.99%
+476.04K
+7.90%
Dec 31, 2025
Citi Investment Research (US)
5.25M
4.83%
+5.24M
+50224.69%
Dec 31, 2025
Two Sigma Investments, LP
4.01M
3.69%
+603.18K
+17.71%
Dec 31, 2025
Suvretta Capital Management, LLC
2.99M
2.76%
-850.60K
-22.13%
Dec 31, 2025
Morgan Stanley & Co. LLC
2.84M
2.61%
+173.79K
+6.52%
Dec 31, 2025
Newtyn Management, LLC
2.65M
2.44%
+147.14K
+5.88%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
0.83%
Global X Genomics & Biotechnology ETF
0.42%
WisdomTree BioRevolution Fund
0.38%
Fidelity Enhanced Small Cap ETF
0.05%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
iShares Biotechnology ETF
0.03%
iShares Russell 2000 Value ETF
0.02%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.02%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.83%
Global X Genomics & Biotechnology ETF
Proportion0.42%
WisdomTree BioRevolution Fund
Proportion0.38%
Fidelity Enhanced Small Cap ETF
Proportion0.05%
Invesco Nasdaq Biotechnology ETF
Proportion0.04%
ProShares Ultra Nasdaq Biotechnology
Proportion0.04%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.03%
iShares Biotechnology ETF
Proportion0.03%
iShares Russell 2000 Value ETF
Proportion0.02%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion0.02%
